Literature DB >> 16242189

Diffuse unilateral subacute neuroretinitis in Venezuela.

Rafael Cortez1, John P Denny, Rafael Muci-Mendoza, Gema Ramirez, Darío Fuenmayor, Glenn J Jaffe.   

Abstract

PURPOSE: To describe the clinical features and management of the largest reported series to date of patients with diffuse unilateral subacute neuroretinitis (DUSN).
DESIGN: Observational case series.
METHODS: The charts of all patients coded as having DUSN in a vitreoretinal clinic in Caracas, Venezuela between July 1979 and August 2000 were retrospectively reviewed. MAIN OUTCOME MEASURES: Demographic information, presenting visual acuity, clinical course, and treatment were evaluated.
RESULTS: We identified 82 eyes of 78 patients with DUSN. The mean age at diagnosis was 16.7 years, significantly younger than the mean age of the Venezuelan population. Sixty-five (83.3%) patients were 20 years old or younger (P<0.001 when compared with the population of Venezuela). Thirty-three (42.3%) of the patients were female. The presenting visual acuity was 20/400 or worse in 69 eyes (84.1%). The subretinal nematode was identified in 33 eyes (40.2%). All nematodes were small, approximately 400 microm in length.
CONCLUSIONS: In Venezuela, DUSN is seen primarily in young patients without a significant gender predilection. The vast majority of patients in this population presented with severe vision loss that was irreversible.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242189     DOI: 10.1016/j.ophtha.2005.05.029

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

1.  Diffuse unilateral subacute neuroretinitis in a healthy Korean male: the first case report in Korea.

Authors:  Hae Min Kang; Christopher Seungkyu Lee
Journal:  J Korean Med Sci       Date:  2015-02-16       Impact factor: 2.153

2.  Diffuse unilateral subacute neuroretinitis in the United Kingdom.

Authors:  Evelyne Oueghlani; Eoin O'Sullivan; Carlos E Pavesio
Journal:  Int Ophthalmol       Date:  2010-03-25       Impact factor: 2.031

3.  Diffuse unilateral subacute neuroretinitis: report of a case from the Indian subcontinent and the importance of immediate photocoagulation.

Authors:  Pradeep Venkatesh; Sujoy Sarkar; Satpal Garg
Journal:  Int Ophthalmol       Date:  2007-02-27       Impact factor: 2.031

4.  Cutaneous larva migrans with optic disc edema: a case report.

Authors:  Luna Dhir; Tim O'Dempsey; Mark T Watts
Journal:  J Med Case Rep       Date:  2010-07-07

5.  Baylisascaris Procyonis Induced Diffuse Unilateral Subacute Neuroretinitis in New York City.

Authors:  Norman A Saffra; Jason E Perlman; Rajen U Desai; Kevin R Kazacos; Christina M Coyle; Fabiana S Machado; Sanjay R Kedhar; Michael Engelbert; Herbert B Tanowitz
Journal:  J Neuroparasitology       Date:  2010-01-01

6.  Multimodal imaging-guided diagnosis, management and follow-up of a case of diffuse unilateral subacute neuroretinitis.

Authors:  Obuli Ramachandran; Rachana Mallidi; Sagnik Sen; Naresh Babu Kannan
Journal:  BMJ Case Rep       Date:  2020-04-15

7.  Diffuse unilateral subacute neuroretinitis in a young boy: a case report.

Authors:  Ng Guan-Fook; Abd Aziz Hayati; Mohd Noor Raja-Azmi; Ahmad Tajudin Liza-Sharmini; Wan Hitam Wan-Hazabbah; Embong Zunaina
Journal:  Clin Ophthalmol       Date:  2012-03-27

8.  Short-term oral albendazole therapy for diffuse unilateral subacute neuroretinitis: A case report.

Authors:  Claudia Amaral; Hiram Jimenez; Pedro Davila; Jan P Ulloa-Padilla; Humberto M Guiot; Armando L Oliver
Journal:  Am J Ophthalmol Case Rep       Date:  2021-03-06

9.  Clinical experience in treatment of diffuse unilateral subretinal neuroretinitis.

Authors:  Nidhi Relhan; Avinash Pathengay; Vishal Raval; Sameera Nayak; Himadri Choudhury; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2015-09-28

10.  Case report: a case of diffuse unilateral subacute neuroretinitis (DUSN) in a child.

Authors:  David S Curragh; Anne Ramsey; Sharon Christie; Eibhlin McLoone
Journal:  BMC Ophthalmol       Date:  2018-09-14       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.